[ET Net News Agency, 30 October 2024] IMMUNEONCO-B (01541) rose 9.2% to HK$7.97.
It hits an intra-day high of HK$8.03, and an intra-day low of HK$7.17. The total shares
traded was 4.48 million, with a value of HK$34.44m. The active buy/sell ratio is 66:34,
with net buying turnover of HK$10.65m. HANTEC SEC accounts for greatest net responsive
buying turnover of HK$116,308, with volume weighted average price of HK$7.859. CHINA
INNOVATION MARKET SER accounts for greatest net responsive selling turnover of HK$1.44m,
with volume weighted average price of HK$7.714. The stock has risen a combined 9.5% over
the past 2 consecutive trading days.

Basic Information
=================

---------------------------------
Nominal 7.970 % Chg +9.18%
High 8.030 Low 7.170
Shares Tr 4.48m Turnover 34.44m
10-D SMA 6.503 %H.V 166.970
20-D SMA 6.539 VWAP 7.690
50-D SMA 6.579 RSI14 60.918
---------------------------------
Status: Active buy/sell ratio is 66:34, with net buying turnover of HK$10.65m, rising a
combined 9.5% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
IMMUNEONCO-B (01541) 7.97 +9.18
INNOVENT BIO (01801) 36.05 -2.96
JXR (01951) 3.59 +1.99
EVEREST MED-B (01952) 31.95 +3.57
WUXI BIO (02269) 17.28 +1.17
TIGERMED (03347) 37.30 -6.16
BEIGENE (06160) 128.70 -1.98
CANSINOBIO (06185) 29.25 +11.64
AIM VACCINE (06660) 7.56 +5.29
AKESO (09926) 68.20 -0.44
---------------------------------------------
(ed)